Literature DB >> 29739916

Secondary Stroke Prevention in Atrial Fibrillation: New Insights Into an Old Problem.

M Edip Gurol1.   

Abstract

Entities:  

Keywords:  Editorials; anticoagulants; atrial appendage; atrial fibrillation; secondary prevention; stroke

Mesh：

Substances：

Year:  2018        PMID： 29739916      PMCID： PMC5970993          DOI： 10.1161/STROKEAHA.118.021262

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  5 in total

Review 1.  Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk.

Authors:  M Edip Gurol
Journal:  Stroke       Date:  2017-12-04       Impact factor: 7.914

2.  The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Authors:  Jan Steffel; Peter Verhamme; Tatjana S Potpara; Pierre Albaladejo; Matthias Antz; Lien Desteghe; Karl Georg Haeusler; Jonas Oldgren; Holger Reinecke; Vanessa Roldan-Schilling; Nigel Rowell; Peter Sinnaeve; Ronan Collins; A John Camm; Hein Heidbüchel
Journal:  Eur Heart J       Date:  2018-04-21       Impact factor: 29.983

3.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

4.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors:  David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

5.  Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.

Authors:  Vivek Y Reddy; Ronald L Akehurst; Stacey L Amorosi; Meghan B Gavaghan; Deanna S Hertz; David R Holmes
Journal:  Stroke       Date:  2018-05-08       Impact factor: 7.914
  5 in total
  1 in total

1.  Updates on Prevention of Cardioembolic Strokes.

Authors:  Mehmet Akif Topcuoglu; Liping Liu; Dong-Eog Kim; M Edip Gurol
Journal:  J Stroke       Date:  2018-05-31       Impact factor: 6.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.